LCE3B-E Activators

LCE3B-E activators are a class of chemical compounds specifically designed to target and activate the late cornified envelope (LCE) genes, particularly LCE3B and LCE3E. These genes are part of the epidermal differentiation complex (EDC), which plays a critical role in skin barrier formation and repair. The LCE proteins are expressed in the upper layers of the epidermis and are involved in the final stages of epidermal differentiation, contributing to the formation of the cornified envelope, a key component of the skin barrier. Activation of LCE3B and LCE3E genes can potentially enhance the skin's ability to repair itself and improve barrier function, making these activators of interest for research in dermatological conditions where the skin barrier is compromised, such as in eczema, psoriasis, and ichthyosis.

The discovery and development of LCE3B-E activators typically involve high-throughput screening (HTS) of large chemical libraries to identify compounds that can upregulate the expression of these genes or enhance the activity of their encoded proteins. This process utilizes reporter assays, real-time PCR, and other gene expression analysis techniques to screen for compounds that show a positive effect on LCE3B and LCE3E activity. Once potential activators are identified, structure-activity relationship (SAR) studies are conducted to optimize these compounds for increased efficacy and specificity. These studies involve systematic modifications to the chemical structure of the lead compounds to elucidate the features necessary for their activity and to improve their selectivity for LCE3B and LCE3E over other members of the EDC. Additionally, in vitro and in vivo models of skin differentiation and barrier formation are employed to assess the functional effects of these activators on skin physiology, including their ability to enhance barrier repair and modulate epidermal differentiation.